课题基金 / 基金详情

Orphan nuclear receptor TLX signaling in neural stem cells

Orphan nuclear receptor TLX signaling in neural stem cells
神经干细胞中的孤儿核受体 TLX 信号传导
批准号:
7454473
负责人:
YANHONG SHI
金额:
$36.97万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2011-06-30

项目摘要

项目成果

YANHONG SHI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):干细胞技术为治疗目前缺乏有效疗法的各种人类疾病提供了巨大的希望。确定控制干细胞自我更新的因素是将干细胞技术从实验室推向临床的重要一步。在调节这一过程中起重要作用的一个因素是孤儿核受体TLX。TLX在哺乳动物脑中特异性表达,对于维持成体神经干细胞处于未分化和自我更新状态至关重要。本研究的目的是通过鉴定TLX的下游靶基因和上游调控因子来揭示TLX的级联调控机制。这项研究对于实施基于神经干细胞的细胞替代疗法治疗神经退行性疾病(如阿尔茨海默病和帕金森病)和脑损伤至关重要。本研究的结果将为TLX信号通路提供新的见解,并定义控制神经干细胞维持和自我更新的新元件。TLX信号网络的每一个组成部分,无论是下游靶基因还是上游调节因子,都将成为干预神经退行性疾病的新分子靶点。
英文摘要
DESCRIPTION (provided by applicant): Stem cell technology holds great promise for the treatment of a variety of human diseases that currently lack effective therapies. Identifying factors that control stem cell self-renewal is an important step in moving stem cell technology from the laboratory to the clinics. One factor that plays an important role in regulating this process is orphan nuclear receptor TLX. TLX is specifically expressed in mammalian brains and is essential to maintain adult neural stem cells in the undifferentiated and self-renewable state. The objective of this study is to uncover the regulatory cascade of TLX by identifying its downstream target genes and upstream regulators. This study will be critical to the implementation of neural stem cell-based cell replacement therapy for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's diseases and brain injuries. The results of this study will provide new insights into TLX signaling pathway and define novel elements that control neural stem cell maintenance and self-renewal. Each component of the TLX signaling network, either downstream target genes or upstream regulators, will be novel molecular targets for intervening neurodegenerative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Define the effect of CLU SNP on the risk to Alzheimer's disease
Develop age-relevant glial cellular models using human directly reprogrammed cells
Develop age-relevant glial cellular models using human directly reprogrammed cells
A Human iPSC-based Cell Therapy for Canavan Disease
海外基金